• MicroPort CardioFlow’s non-executive director Brian Chang resigned effective October 30, 2026, to devote more time to professional commitments.
• Chang also stepped down as Strategy Committee chair and as a member of the Audit and Commercialization committees.
• Executive director Chen Guoming, previously a Strategy Committee member, became its chair.
• Chen will temporarily preside over board meetings and coordinate board operations pending the appointment of a new chairman.
• Non-executive director Deng Aoyi and independent non-executive director Mao Junxiang joined the Audit Committee.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microport Cardioflow Medtech Corporation published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261101-12391793), on November 01, 2026, and is solely responsible for the information contained therein.